Disease progression more than 6 years after treatment impacts overall survival in mantle cell lymphoma. Ekberg S, Glimelius I, Albertsson-Lindblad A, Smedby KE, et al. Int J Cancer 2025 Nov 5. doi: 10.1002/ijc.70220.

Read + Share

Amedeo Smart

Independent Medical Education

Ekberg S, Glimelius I, Albertsson-Lindblad A, Smedby KE, et al. Disease progression more than 6 years after treatment impacts overall survival in mantle cell lymphoma. Int J Cancer 2025 Nov 5. doi: 10.1002/ijc.70220.
PMID: 41189519